Arterial Spin Labeling Magnetic Resonance Imaging

PROCEDURE3 trials

Sponsors

Beth Israel Deaconess Medical Center, Rutgers, The State University of New Jersey, Jonsson Comprehensive Cancer Center

Conditions

Malignant Brain NeoplasmRenal Cell CarcinomaStage I Renal Cell CancerStage II Renal Cell CancerStage III Renal Cell CancerStage IV Renal Cell Cancer

Unknown Phase

Arterial Spin Labeling Blood Flow MRI for Evaluation of Response to Antiangiogenic and Targeted Therapies of Renal Cell Carcinoma (RCC)

CompletedNCT00749320

Beth Israel Deaconess Medical CenterRenal Cell Carcinoma

Start: 2008-09-30End: 2019-12-31Updated: 2020-02-26

Perfusion Magnetic Resonance Imaging in Diagnosing Patients With Kidney Tumors

Rutgers, The State University of New JerseyStage III Renal Cell Cancer, Stage II Renal Cell Cancer, Stage I Renal Cell Cancer +1

Start: 2015-04-15End: 2025-09-07Updated: 2023-04-11

Quantifying Oxygen Utilization of Tumors Using Oxygen-Enhanced Molecular MRI

TerminatedNCT04460495

Jonsson Comprehensive Cancer CenterMalignant Brain Neoplasm

Start: 2020-07-07End: 2021-09-16Updated: 2022-05-10

Related Papers

Arterial Spin Labeled Perfusion MRI for the Evaluation of Response to Tyrosine Kinase Inhibition Therapy in Metastatic Renal Cell Carcinoma

Radiology2020-12-0114 citations